Kathryn Fantauzzi is the chief executive officer and co-founder at Apollo Neuroscience, Inc. where she leads all Apollo strategy and development. Kathryn is experienced in leading cross-functional teams to bring products and services to market.
As CEO, she recruited a seasoned team of business leaders, engineers, designers, and physicians with multiple prior exits to launch Apollo. Prior to Apollo, Kathryn managed a $20M fund to evaluate and advance commercialization of emerging technologies for NYSERDA. Kathryn formed Apollo Neuroscience in 2017 to accelerate the development and translation of novel neuroscience discoveries to address public health needs and improve outcomes.
Apollo helps you adapt to every rhythm. Developed by physicians and neuroscientists, Apollo’s goal-based programs deliver customized vibration patterns designed to restore your body’s natural equilibrium.
Apollo, a new wearable experience, looks to offset those symptoms and restore the body’s natural equilibriumApollo is the only technology to improve sleep and cognitive performance by delivering vibration through a wearable.
For more information visit: